Magic mushroom therapy gets second shot at easing cancer anxiety
NCT ID NCT06644170
Summary
This small, early-stage study tested whether a second round of psilocybin-assisted group therapy is safe and helpful for people with advanced cancer who still have significant anxiety after a first session. Fifteen participants with metastatic cancer received psilocybin in a controlled group retreat setting, supported by preparation and follow-up therapy sessions. The main goal was to check for safety and side effects, while also seeing if this second experience could further reduce anxiety and distress.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
Conditions
Explore the condition pages connected to this study.